Next Article in Journal
Efficient Confirmation of Plant Viral Proteins and Identification of Specific Viral Strains by nanoLC-ESI-Q-TOF Using Single-Leaf-Tissue Samples
Previous Article in Journal
Clinical Symptoms of Arboviruses in Mexico
Case Report

COVID-19 as a Trigger of Recurrent Guillain–Barré Syndrome

1
Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
2
Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
3
Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, NJ 08854, USA
*
Author to whom correspondence should be addressed.
Pathogens 2020, 9(11), 965; https://doi.org/10.3390/pathogens9110965
Received: 21 September 2020 / Revised: 11 November 2020 / Accepted: 17 November 2020 / Published: 19 November 2020
(This article belongs to the Section Human Pathogens)
Coronavirus 2019 (COVID-19) has been reported to trigger Guillain–Barré syndrome (GBS). While uncommon, recurrent GBS (rGBS) episodes, triggered by antecedent viral infections, have been reported in a small proportion of GBS patients, here we describe a patient with a recurrent case of GBS, occurring secondary to COVID-19 infection. Before this patient’s episode, he had two prior GBS flares, each precipitated by a viral infection followed by complete recovery besides intermittent paresthesias. We also consider the nosology of this illness in the spectrum of rGBS and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), with their differing natural histories, prognosis, and therapeutic approaches. For patients who have a history of inflammatory demyelinating polyradiculopathies who develop COVID-19, we recommend close observation for neurologic symptoms over the next days and weeks. View Full-Text
Keywords: SARS-CoV-2 neurological complications; recurrent Guillain–Barré syndrome; para-infectious Guillain–Barré syndrome; Chronic Inflammatory Demyelinating Neuropathy; demyelinating polyradiculopathies SARS-CoV-2 neurological complications; recurrent Guillain–Barré syndrome; para-infectious Guillain–Barré syndrome; Chronic Inflammatory Demyelinating Neuropathy; demyelinating polyradiculopathies
Show Figures

Figure 1

MDPI and ACS Style

McDonnell, E.P.; Altomare, N.J.; Parekh, Y.H.; Gowda, R.C.; Parikh, P.D.; Lazar, M.H.; Blaser, M.J. COVID-19 as a Trigger of Recurrent Guillain–Barré Syndrome. Pathogens 2020, 9, 965. https://doi.org/10.3390/pathogens9110965

AMA Style

McDonnell EP, Altomare NJ, Parekh YH, Gowda RC, Parikh PD, Lazar MH, Blaser MJ. COVID-19 as a Trigger of Recurrent Guillain–Barré Syndrome. Pathogens. 2020; 9(11):965. https://doi.org/10.3390/pathogens9110965

Chicago/Turabian Style

McDonnell, Erin P., Nicole J. Altomare, Yesha H. Parekh, Ram C. Gowda, Payal D. Parikh, Mark H. Lazar, and Martin J. Blaser 2020. "COVID-19 as a Trigger of Recurrent Guillain–Barré Syndrome" Pathogens 9, no. 11: 965. https://doi.org/10.3390/pathogens9110965

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop